Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ambea ABCHIX:AMBEAS 79 Earnings per Share (Diluted) is kr8.53 as of Mar. 2026. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 79/100 and a GF Value™ of kr112.45 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Ambea AB ranks better than 68.44% on this metric.
Ambea AB's EPS (Basic) for the
three
months ended in Mar. 2026 was kr2.03.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was kr8.55.
Ambea AB's EPS without NRI for the
three
months ended in Mar. 2026 was kr2.02.
Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was kr8.53.
During the past 12 months, Ambea AB's average EPS without NRIGrowth Rate was 15.90% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 26.20% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 22.10% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 31.80% per year.
During the past 12 years, Ambea AB's highest 3-Year average EPS without NRI Growth Rate was 264.80% per year. The lowest was -14.20% per year. And the median was 15.90% per year.
Ambea AB (CHIX:AMBEAs) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Ambea AB Earnings per Share (Diluted) Related Terms
Ambea AB Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Ambea AB's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AMBEAS vs HCA, THC, DVA: Earnings per Share (Diluted) Comparison
For the Medical Care Facilities subindustry, Ambea AB's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambea AB PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's PE Ratio distribution charts can be found below:
* The bar in red indicates where Ambea AB's PE Ratio falls into.
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Ambea AB's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr8.53
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of kr8.53 mean?
Ambea AB (CHIX:AMBEAS) has a Earnings per Share (Diluted) of kr8.53 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Ambea AB and its competitors. According to the industry distribution chart, Ambea AB ranks #160 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 31.6%.
Is Ambea AB's Earnings per Share (Diluted) too high?
Ambea AB's current Earnings per Share (Diluted) is kr8.53. Based on the distribution chart, Ambea AB ranks #160 out of 507 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ambea AB has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's Earnings per Share (Diluted) compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #160 out of 507 companies for Earnings per Share (Diluted). This puts Ambea AB in the upper half of its industry. The industry median Earnings per Share (Diluted) is 11.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.30, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Ambea AB and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambea AB's current Earnings per Share (Diluted) is kr8.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr112.45, compared to a current price of kr144.20 — trading 28.2% above its estimated fair value. The current Earnings per Share (Diluted) is kr8.53. Ambea AB's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current Earnings per Share (Diluted) is kr8.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?
Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued.
The current stock price of kr144.20 is trading 28.2% above its estimated GF Value™ of kr112.45.
GuruFocus considers Ambea AB to be Modestly Overvalued.
Key valuation signals for CHIX:AMBEAS:
Earnings per Share (Diluted): kr8.53
GF Value™: kr112.45 vs. price of kr144.20 (28.2% above fair value)
No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
79GF Score
Get the complete analysis for CHIX:AMBEAS
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMBEAS has been successfully added to your 
